
    
      RA satisfaction OR: This study aim to compare treatment satisfaction and quality of life
      between patients who have been using tofacitinib citrate and patients who have been using
      adalimumab for 6 months or more and less than 2 year in RA treatment of rheumatoid arthritis.

      Study design: Non-interventional, multi-centers, cross-sectional study
    
  